Company / Free Cash Flow per Share
Editas Medicine, Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.65
FY2025
5-year range
-$2.73 / -$0.75
FY2021-FY2025
Trend
-19.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 8 years, ranging from $-2.73 in FY2022 to $-0.24 in FY2019.
Based on SEC 10-K filings.
-2.65 in FY2025.
Declined from $-2.50 to $-2.65 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 19.3% year-over-year.
- Peak free cash flow per share was recorded in FY2019.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.65 | -19.3% |
| FY2024 | -$2.22 | +11.1% |
| FY2023 | -$2.50 | +8.7% |
| FY2022 | -$2.73 | -265.0% |
| FY2021 | -$0.75 | +19.4% |
| FY2020 | -$0.93 | -294.4% |
| FY2019 | -$0.24 | +80.5% |
| FY2018 | -$1.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026